InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Neumann Mark, Chief Financial Officer. Director active across 1 companies, notably Intra-Cellular Therapies, Inc.. In total, 7 filings have been logged. The latest transaction was filed on 8 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
€1m86,348 shares@ €11.7167100.0% of flow
Common Stock
SEC:0001209191-22-023901:0·
7,906 shares
Common Stock
SEC:0001209191-22-013359:0·
11,139 shares
Common Stock
SEC:0001209191-22-012394:0·
20,948 shares
Common Stock
SEC:0001209191-22-002991·
20,948 shares
Common Stock
SEC:0001209191-22-002991:0·
13,448 shares
Common Stock
SEC:0001209191-21-060907·
13,448 shares
Common Stock
SEC:0001209191-21-060907:0·
7 of 7 declarations
About Neumann Mark
Mark Alan Jeffries serves as Chief Financial Officer at Select Bancorp, Inc. He is responsible for the company's financial management, including financial planning, accounting, and risk management. Mark plays a vital role in developing financial strategies that support the growth and sustainability of Select Bancorp.
